A proteomics-based identification of putative biomarkers for disease in bovine milk  by van Altena, S.E.C. et al.
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The  objective  of  this  study  was  to  identify  and  characterize  potential  biomarkers  for disease  resistance  in
bovine  milk  that  can  be  used  to  indicate  dairy  cows  at risk  to  develop  future  health  problems.  We  selected
high-  and low-resistant  cows  i.e. cows  that  were  less  or more  prone  to develop  diseases  according  to
farmers’  experience  and  notiﬁcations  in  the  disease  registration  data. The  protein  composition  of  milk
serum  samples  of  these  high-  and  low-resistant  cows  were  compared  using NanoLC–MS/MS.  In  total  78
proteins were  identiﬁed  and quantiﬁed  of  which  13  were  signiﬁcantly  more  abundant  in low-resistant
cows  than high-resistant  cows.  Quantiﬁcation  of one  of these  proteins,  lactoferrin  (LF),  by  ELISA in  a
new  and  much  larger  set  of  full fat milk samples  conﬁrmed  higher  LF  levels  in  low- versus  high-resistant
cows.  These  high-  and  low-resistant  cows  were  selected  based  on  comprehensive  disease  registration
and  milk  recording  data,  and absence  of  disease  for at least  4 weeks.  Relating  the  experienced  diseases
to  LF  levels  in milk  showed  that  lameness  was  associated  with  higher  LF  levels  in  milk.  Analysis  of the
prognostic  value  of LF showed  that  low-resistant  cows  with  higher  LF  levels  in milk  had a  higher  risk  of
being  culled  within  one  year  after  testing  than  high-resistant  cows.  In conclusion,  LF in milk  are higher  in
low-resistant  cows,  are  associated  with  lameness  and  may  be a prognostic  marker  for risk  of  premature
culling.
© 2016  The  Authors.  Published  by  Elsevier  B.V.  This  is  an open  access  article  under  the  CC  BY  license. Introduction
The objective of this study was to identify biomarkers for dis-
ase resistance in bovine milk, thereby providing a prognostic tool
o indicate dairy cows at risk to develop future health problems.
he last decades dairy farming in the Netherlands has changed
normously and the number of cows per farm increased with 40%
uring the last 10 years (CRV, 2015). Clinical mastitis, one of the
ajor health problems in dairy farming, has an incidence of about
3 cases per 100 cows annually (Santman-Berends et al., 2015)
ith associated annual costs of approximately D 61 to D 97 per cow
ased on worldwide estimations (Hogeveen et al., 2011). Also fer-
ility problems and lameness are important issues in dairy farming
Huxley, 2013; Weaveret al., 2007). About 75% of the diseases in
∗ Corresponding author at: De Elst 1, 6708 WD Wageningen, The Netherlands.
E-mail address: christine.vanaltena@wur.nl (S.E.C. van Altena).
ttp://dx.doi.org/10.1016/j.vetimm.2016.04.005
165-2427/© 2016 The Authors. Published by Elsevier B.V. This is an open access article u(http://creativecommons.org/licenses/by/4.0/).
dairy cows occur in the ﬁrst month after calving (LeBlanc et al.,
2006). Around parturition, the immune system is compromised and
the feed intake does not meet the energy requirements of the cow
resulting in a negative energy balance (NEB), which makes the cow
susceptible for diseases (Ingvartsen and Moyes, 2013; LeBlanc et al.,
2006; van Knegsel et al., 2007).
To monitor the health status of cows, several studies were
performed to obtain speciﬁc biomarkers. For example the energy
balance, and thereby the risk of developing disease, can be
measured by the levels of not-esteriﬁed fatty acids (NEFA) and beta-
hydroxybutyrate (BHBA) in blood (Ospina et al., 2010). Pre-partum
NEFA serum levels were shown to be positively correlated with
the risk of mastitis after parturition (Holtenius et al., 2004; Moyes
et al., 2009b). High post-partum NEFA levels are also a predictor
for clinical ketosis, retained placenta, metritis and displaced abo-
masum (Ospina et al., 2010). Acute phase proteins (APP) in cows,
like haptoglobin and serum amyloid, are common markers for
infection and inﬂammation (Ceciliani et al., 2012; Eckersall and Bell,
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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010; Eckersall et al., 2006). Haptoglobin and mammary-associated
erum amyloid A (M-SAA3) were consistently increased in milk and
ubsequently in blood after a Staphylococcus aureus-induced sub-
linical mastitis (Eckersall et al., 2001; Eckersall et al., 2006). In milk,
n increase in somatic cell counts (SCC) or lactate dehydrogenase
LDH) are markers for mastitis (Åkerstedt et al., 2011; Hiss et al.,
007) and are now routinely tested. Furthermore, ketosis can also
e determined in milk by the rise in BHBA levels.
The risk for development of important diseases in dairy cat-
le can thus be monitored by the levels of some of these markers,
hich are used for regular screening in dairy farming already. A
egularly used marker like SCC is speciﬁcally related to detection
f mastitis, but does not indicate other diseases. Therefore, we  are
iming for prognostic markers in bovine milk that are related to dis-
ases different than mastitis. Markers in milk are preferred since
ilk samples are already collected regularly for routine screen-
ng, in contrast to blood samples. Nowadays, hundreds of unique
roteins can be identiﬁed in different fractions of bovine milk by
ass spectrometry (Hettinga et al., 2011; Nissen et al., 2013). This
akes a proteomics approach a valuable tool for discovery of novel
iomarkers (Boehmer et al., 2010; Ferreira et al., 2013). Here, we  use
hotgun proteomics (NanoLC–MS/MS) to compare milk samples of
ows with a good health history (high-resistant cows) to milk sam-
les of cows with a poorer health history (low-resistant cows). In
his study, we consider high-resistant cows as having a low suscep-
ibility to the development of disease. Likewise low-resistant cows
ave a high susceptibility for disease development. To exclude the
etection of acute disease related markers, all samples were taken
rom cows that had not experienced health problems in the pre-
eding 4 weeks. With this approach, we aimed to identify novel
andidate biomarkers in milk for disease incidence in dairy cows,
hich were then evaluated in a larger number of milk samples from
igh- and low-resistant cows, selected on basis of comprehensive
isease registration data collected during this study.
. Materials and methods
.1. Samples
Milk samples were obtained from the Resilient Cattle (“Weer-
aar Vee”) biobank established in the Netherlands from 2010 until
015. Cows from 29 conventional Dutch dairy farms were sam-
led multiple times during this period with the highest sampling
requency in 2014. In 2014, all full fat milk samples tested in the
eneral milk recording and monitoring program were also stored
n Resilient Cattle biobank at −80◦ C (5–14 samples per cow). The
verage number of dairy cows per farm was 114 with a range of
3–266 cows. From 2010 until 2015 comprehensive disease regis-
ration data of these cows were collected. The disease registration
ata were carefully documented as instructed and supervised by
ne veterinarian and contained information about the diseases,
pplied treatments and medications the cows received including
ata about the duration of disease and treatment, vaccinations and
oof trimming. Diseases were categorised by the same veterinarian
nto: mastitis, other udder problems, lameness, retained placenta,
etritis (uterus-related problems), respiratory diseases, metabolic
iseases (e.g. ketosis) and “other” (diseases different than the pre-
ious categories for example trauma due to accidents).
First, milk serum (whey) samples used for proteomics analysis
ere selected based on the farmer‘s opinion on perceived disease
esistance of the cows in combination with disease registration
ata. At that moment, the average number of dairy cows per farm
as 108 with a range of 59–230 cows. In consultation with the
eterinarian, farmers were asked to identify their ﬁve highest and
ve lowest performing cows in terms of health problems, whichand Immunopathology 174 (2016) 11–18
are henceforward called high- and low-resistant cows. These cows
were checked for health problems using the recorded disease regis-
tration data and milk recording data. Cows with somatic cell counts
above 250,000 cells/ml were excluded to reduce the chance on
including cows with an ongoing mammary infection (Sampimon
et al., 2010). In addition, cows were excluded with annotations in
the disease registration data within one month before or after the
moment of sampling. High-resistant cows had no or only minor
health problems, while low-resistant cows had recurrent health
problems. Four high-resistant and four low-resistant cows were
selected for proteomics analysis. These two group of cows were
matched for age, parity, milk production, somatic cell counts (SCC),
fat percentage, protein percentage and days in milk (DIM). At the
moment of milk sampling all cows in both groups were clinically
healthy based on disease registration and milk recording data.
The individual milk serum samples were compared to a pooled
of milk serum sample derived from 26 cows. This randomly cho-
sen “average group” is matched to both groups of low-resistant
and high-resistant individual samples in terms of age, parity, milk
production, SCC, fat percentage, protein percentage and DIM.
The second and larger group of 43 high- and 36 low-resistant
cows were selected based on the disease registration data obtained
from the beginning of 2010 until summer 2014. Cows in the high-
and low-resistant groups were matched for farm (n = 9), age, par-
ity, milk production, SCC, fat percentage, protein percentage and
DIM. Other inclusion criteria for the cows were: raised on the
selected farms, born between 2008 and 2011, more than 30 days
in lactation, production above the average production per farm
and somatic cell count at sampling below 250,000 cells/ml. High-
resistant cows had no annotations in the comprehensive disease
registration data except for vaccinations. Farmers were carefully
instructed and coached by the same veterinarian in keeping the dis-
ease registration accurate and up to date. Low-resistant cows had
at least two annotations in the disease registration data (excepting
regular vaccinations).
2.2. NanoLC–MS/MS
Milk serum samples were prepared by centrifugation at 1500g
for 10 min  at 10◦ C. The supernatant was collected (without fat
layer) and diluted 1:1 in 0.05 M ammonium bicarbonate buffer
pH = 8.0 (ABC buffer, NH4HCO3 in water), then ultra-centrifuged
at 100,000g for 90 min  at 30◦ C. The clear supernatant (milk serum)
was collected and prepared for proteomics analysis as described by
(Zhang et al., 2015b). Milk serum samples were treated using the
ﬁlter-aided sample preparation (FASP) method (Wisniewski et al.,
2009) to clean the samples and perform trypsin digestion. After
trypsin digestion, the resulting peptides were labelled by dimethyl
labelling (Lu et al., 2011). The amine-group of each peptide reacts
with formaldehyde (for light label) or deuterated formaldehyde
(for heavy label) forming a so called Schiff base, which is subse-
quently reduced by cyanoborohydride resulting in a light or heavy
label attached to each peptide (Boersema et al., 2009). The milk
serum samples from high- and low-resistant cows were individ-
ually labelled with a light label and compared to a pool of milk
serum from 26 cows containing a heavy label. Protein quantity is
expressed as a log2 ratio of the individual milk serum samples to
the pooled milk serum sample. All eight individual samples can be
compared with each other due to this labelling approach.
NanoLC–MS/MS analysis was performed as described by (Zhang
et al., 2015a). Full scan positive mode FTMS spectra were measured
between m/z 380 and 1400 on a LTQ-Orbitrap XL (Thermo elec-
tron, San Jose, CA, USA) in the Orbitrap at high resolution (60,000).
CID fragmented MSMS  scans of the four most abundant 2+ and 3+
charged peaks in the FTMS scan were recorded in data dependent
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ode in the linear trap (MSMS  threshold = 5.000, 45s exclusion
uration for the selected m/z  +/−25 ppm).
LC–MS runs with all MSMS  spectra obtained were analysed with
axQuant 1.3.0.5 (Cox and Mann, 2008) using default settings for
he Andromeda search engine (Cox et al., 2011) except that extra
ariable modiﬁcations were set for de-amidation of N and Q.
A bovine database downloaded from Uniprot (http://www.
niprot.org) was used together with a contaminants database
hat contains sequences of common contaminants as for instance:
SA (P02769, bovine serum albumin precursor), Trypsin (P00760,
ovine), Trypsin (P00761, porcine), Keratin K22E (P35908, human),
eratin K1C9 (P35527, human), Keratin K2C1 (P04264, human) and
eratin K1CI (P35527, human).
In the MaxQuant analysis, only peptides and proteins with a
alse discovery rate (FDR) of less than 1% were accepted. Reversed
its were deleted from the MaxQuant protein groups result table.
he protein groups result was ﬁltered further to keep only proteins
ith at least 2 identiﬁed peptides of which at least one should be
nique and at least one should be unmodiﬁed.
.3. Lactoferrin ELISA
The bovine lactoferrin ELISA was performed according to man-
facturer instructions (Bovine Lactoferrin ELISA Quantitation Set,
ethyl Laboratories Inc., Montgomery USA). Milk samples were
iluted 500, 1000 or 4000 times in Blocking Reagent (Roche Applied
cience, Mannheim, Germany). All samples and standards were
repared and measured in duplicate at 450 nm using a Filtermax F5
late Reader (Molecular Devices, Sunnyvale, California). The within
ssay coefﬁcient of variation is <5% (Soyeurt et al., 2012).
.4. Gamma  glutamyltransferase 1 ELISA
Levels of gGT1 were determined using the bovine gamma
lutamyltransferase 1 ELISA kit according to the manufacturers‘
nstructions (NovaTeinBio, Woburn, USA).
.5. Statistical analysis
Groups of high- and low-resistant cows were matched for age,
arity, milk production, SCC, fat percentage, protein percentage and
IM. The association of disease status or condition with LF levels
ere analysed with PROC MIXED in SAS 9.3 (SAS Inst. Inc. Cary, NC).
o approximate normality, the natural logarithm (ln) of LF levels
ere calculated and analysed. Preliminary analyses indicated that
he ﬁxed continuous effect of a 305 days milk production in kg, age
f the cows in years, DIM, the interaction between age and DIM, and
he random class effect of farms (farm 1–9) signiﬁcantly affected LF
evels. These effects were, therefore, maintained as correction fac-
ors within the models (base model). Inspection of the distribution
f the residuals and the Q-Q plot indicated 2 possible outliers which
ere LF levels below the detection limit. These observations were,
herefore, removed from the dataset, resulting in 43 high-resistant
nd 34 low-resistant cows.
To assess whether disease status or condition status was
ssociated with LF levels, disease and condition variables were cat-
gorized into a limited set of different classes as some categories
nly had 1 observation. For mastitis, lameness, metabolic diseases
nd retained placenta the data were converted to a binary trait con-
isting of either having a condition (1) or not having a condition
0). For metritis the data was categorized in three classes consist-
ng of having metritis once (1), having metritis more than once (2)
r not having metritis (0). The ﬁxed class effect of disease status or
ondition status was then individually added to the base model in
eparate analyses. To assess whether signiﬁcant differences exist
etween cows that are not ill and cows that are ill with or withoutand Immunopathology 174 (2016) 11–18 13
a certain condition, cows were categorized for each individual con-
dition as either not ill, ill with a condition, or ill without a condition.
These categories were individually added to the base model in sep-
arate analyses. Results are displayed in vertical scatter plots as the
original individual observation (uncorrected LF level in g/ml) for
each disease status and/or condition.
3. Results
3.1. Comparison of milk serum samples of high- and
low-resistant cows by proteomics
To characterize potential biomarkers for disease resistance in
dairy cows, differences in milk serum proteins between 4 high-
and 4 low-resistant cows were determined by NanoLC–MS/MS.
In total, 78 proteins were identiﬁed and quantiﬁed in these sam-
ples (Supplementary Table 1). Each protein is represented in Fig. 1
as a log2 ratio of the protein abundance in high-resistant versus
low-resistant cows. Log2 protein ratios between −1 and 1 were
considered as natural variation, which may  be caused by, for exam-
ple, differences in cow genetics and individual farms. The proteins
outside these limits may  indicate true variation between high-
and low-resistant cows. The expression of 10 proteins was  sig-
niﬁcantly (p < 0.05) different between the high- and low-resistant
cows (open squares in Fig. 1). All 10 proteins were 2.3–6 times more
abundant in milk serum of low-resistant than high-resistant cows
(Table 1). To reduce the chance of missing potential biomarkers,
while testing only a small number of cows, initially also proteins
with 0.05 < p < 0.07 were included, which resulted in the inclusion
of 3 additional proteins (open triangles in Fig. 1) and a total of 13
proteins. The cut-off at p < 0.07 was chosen to include potential
biomarkers, but still outside the natural variation between cows
(log2 protein ratios between −1 and 1). The proteins that were
selected were detected in at least 3 out of 4 cows per group.
3.2. Selection potential biomarkers
The 13 proteins that differed between high- and low-resistant
cows (p < 0.07) were judged for their potential as a biomarker for
bovine health. Most proteins were membrane-bound and were
therefore less suitable as a biomarker since sample preparation
and protein quantiﬁcation with a high-throughput technique like
ELISA is more difﬁcult (Table 1). We  therefore selected two soluble
proteins for further investigation: gamma-glutamyl transpeptidase
1 (gGT1) and lactoferrin (LF). Gamma-GT1 is an enzyme involved
in the Meister glutamyl cycle and is responsible for the transfer
of glutathione across the cell membrane to maintain homeostasis
(Meister and Anderson, 1983). Furthermore, gGT1 levels in blood
are related to liver performance and intoxication (Pompella et al.,
2007). Gamma  GT1 levels measured in urine can be an indicator for
renal damage (Ferguson et al., 2008). The association with disease
and damage makes gGT1 in milk an interesting candidate marker
for disease resistance. Lactoferrin is a glycoprotein produced by
glandular epithelial cells and neutrophils and is present in all body
ﬂuids. It is part of the innate immune system and has antimicrobial,
antiviral, antifungal, anti-inﬂammatory and anti-oxidative prop-
erties, among others by iron sequestering (García-Montoya et al.,
2012; Kanwar et al., 2015) and can also act as an acute phase protein
(Tothova et al., 2014).
3.3. LF levels in milk of high- and low-resistant cows, selected on
disease registration dataNew, full fat milk samples were selected from the “Resilient cat-
tle” biobank to determine if LF and gGT1 were suitable markers for
health-related problems in cows. Milk samples of 43 high-resistant
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Fig. 1. Ratio of milk serum proteins of high- to low-resistant cows.
The diamonds, triangles and squares indicate the proteins found in milk serum samples from 4 high- and 4 low-resistant cows (n = 78). Proteins are represented as a log2 ratio
of  (ratio protein expression in high-resistant cows/protein expression in pooled milk sample) divided by (ratio protein expression in low-resistant cows/protein expression
in  pooled milk sample). Log2 protein ratios between −1 and 1 are considered as natural variation. Open squares: proteins that differ between high-and low-resistant cows
(p  < 0.05). Open triangles: proteins that differ between high- and low-resistant cows (0.05 < p < 0.07). The abbreviations correspond to the proteins listed in Table 1.
Table 1
Milk serum proteins that differ between high- and low-resistant cows.
Protein Full name Uniprot ID Subcellular location Fold change p-value
CD9 CD9 antigen P30932 M 6.0 0.037
GGT1  Uncharacterised protein;
Gamma-glutamyl transpeptidase 1,
gamma-glutamyltransferase 1
G3N2D8 M,  S 5.4 0.024
SLC34A2 Solute carrier family 34 (sodium-dependent
phosphate transport protein 2B) member 2
F1N6D4 M 5.1 0.039
CSN3  Casein kappa P02668 E 4.6 0.011
BTN1A1 Butyrophilin subfamily 1 member A1 P18892 M 3.6 0.026
LTF  Lactotransferrin P24627 E, S 3.3 0.069
GP2  Uncharacterised protein; Glycoprotein 2,
zymogen granule membrane, pancreatic
secretory granule membrane major
glycoprotein
F1N726 E, S 3.1 0.063
PLIN2/ADFP Perilipin 2, adipophilin, adipose
differentiation-related protein
F1N1N6 M 3.1 0.021
CD36  CD36 molecule, platelet glycoprotein IV,
thrombospondin receptor
P26201 M 3.1 0.034
XDH  Xanthine dehydrogenase/oxidase F1MUT3 C, E 3.0 0.006
IDH1  Isocitrate dehydrogenase 1 (NADP + ) Q9XSG3 C 2.5 0.011
ACTB  Actin, cytoplasmic 1 P60712 C 2.4 0.060
P0C
C
c
h
J
t
s
a
t
t
aUBC  Polyubiquitin 
 = cytosol, E = extra-cellular space, M = membrane, S = secreted.
ows and 34 low-resistant cows were collected based on compre-
ensive disease registration data and milk recording data from
anuary 2010 until July 2015. These cows did not have annota-
ions the disease registration data in the month before and after
ampling. LF and gGT1 levels were determined using commercially
vailable ELISAs. The gGT1 levels in full fat milk samples were below
he detection limit (data not shown) and were therefore not fur-
her investigated. Lactoferrin levels were detectable using ELISA
nd were expressed in g per ml  (Fig. 2). For statistical analysis,H28 C 2.3 0.037
the LF levels were ln transformed and corrected for milk produc-
tion, days in milk (DIM), age, farm and the interaction between
DIM and age as these variables signiﬁcantly inﬂuenced LF levels in
milk. No association was  found for LF levels and somatic cell counts
(data not shown). The least squares means (corrected mean) for LF
levels in full fat milk were 244 g/ml and 311 g/ml for high- and
low-resistant cows, respectively, and were signiﬁcantly higher in
low-resistant cows (p = 0.047) (Fig. 2). This is consistent with the
previous results obtained by NanoLC–MS/MS for the 8 milk serum
S.E.C. van Altena et al. / Veterinary Immunology 
Fig. 2. LF levels in full fat milk samples of high- versus low-resistant cows.
LF  levels were measured in full fat milk samples from 43 high- and 34 low-resistant
cows using ELISA. LF levels were expressed as the original LF concentration in g/ml.
The horizontal line indicates the mean. Statistics were performed on the ln trans-
formed and corrected data. (Correction for farm, 305 days production, age, days in
milk (DIM) and the interaction between age and DIM.) LF levels were signiﬁcantly
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the induction of innate immunity by sequestering iron and therebyigher in low-resistant cows than high-resistant cows (p = 0.047).
amples. This implies that being high- or low-resistant is signiﬁ-
antly associated with LF levels in full fat milk, even after correction
or milk production, DIM, age, farm and the interaction between
IM and age.
.4. Association of LF levels in milk and speciﬁc diseases
Next, we determined if the LF levels in full fat milk were associ-
ted with speciﬁc classes of diseases, independent of the resistance
tatus of the cows. Cow performance was monitored by disease reg-
stration data and milk recording data. Diseases were categorised
n: mastitis, other udder problems, lameness, retained placenta,
etritis, respiratory diseases, metabolic diseases and “other” (dis-
ases different than the previous categories or e.g. trauma). Cows
ith high disease resistance had none of the aforementioned health
roblems, while the low-resistant cows had at least two  times an
nnotation in the disease registration data. Based on disease inci-
ence, the association with LF levels in milk was  determined for
he following health-related problems in cows: mastitis, metabolic
iseases, lameness, metritis and retained placenta (Supplementary
ig. 1).
We  did not observe a signiﬁcant difference in LF levels in milk
etween cows that had mastitis, metabolic diseases, metritis or
 retained placenta in the past and cows without these particu-
ar diseases (Supplementary Fig. 1a–d). Nevertheless, cows that
ad suffered from lameness (n = 14) were signiﬁcantly different
rom cows without lameness (p = 0.024) as cows with lameness had
igher LF levels in their milk (Supplementary Fig. 1e).
.5. Association of LF levels in milk with mastitis and lameness in
igh- and low-Resistant cows
Independent of being high- or low-resistant, LF levels were
etermined with respect to the different diseases. When the high-
nd low-resistance status was taken into account, the low-resistant
ows that had suffered from mastitis showed similar LF levels in
ilk as the low-resistant cows without mastitis (Fig. 3a). Low-
esistant cows with lameness had signiﬁcantly higher LF levels in
ilk compared to high-resistant cows without lameness (p = 0.014)
Fig. 3b). LF levels appeared to be higher in low-resistant cows that
ad suffered from lameness compared to low-resistant cows with-
ut lameness, although, this difference was not signiﬁcant (p = 0.13)
Fig. 3b).and Immunopathology 174 (2016) 11–18 15
3.6. Prognostic value lactoferrin
The LF levels were measured in milk samples collected during
the summer of 2014. One year later, summer 2015, we  investi-
gated which of the high-and low-resistant cows were culled or
not as an indicator for cow performance. Fig. 4 shows the LF lev-
els in full fat milk of high- and low-resistant cows that were
still alive and those that were culled within one year. The low-
resistant cows that were culled within one year after sampling had
on average higher LF levels (least squares means = 394.0 g/ml)
than high-resistant cows that were alive (265.2 g/ml), high-
resistant cows that were culled (166.1 g/ml) and low-resistant
cows that were still alive (288.6 g/ml). This difference was signif-
icant between high-resistant cows that were still on the farm and
low-resistant cows that were culled within one year (p = 0.035) and
between high- and low-resistant cows that were culled (p = 0.0017)
(Fig. 4). A similar trend was observed for low-resistant cows that
were still alive and those that were culled (p = 0.10). In addition,
high-resistant cows that were culled had lower LF levels in milk
compared to high-resistant cows that were still alive (p = 0.041) and
low-resistant cows that were still alive (p = 0.017). Taken together,
these results indicate that low-resistant cows with higher LF levels
had a higher chance of being culled.
4. Discussion
In this study we identiﬁed LF as a putative marker for lame-
ness with prognostic value for early culling. Potential biomarkers
were characterised in milk to indicate cows that are at risk to
develop disease using a proteomics-based approach. The initial
comparison of milk serum samples from 4 high- versus 4 low-
disease-resistant cows revealed 13 proteins that were differentially
expressed between both groups (ten p < 0.05 and three p < 0.07).
These proteins were all more abundantly detected by proteomics
in milk serum of low-resistant cows compared to high-resistant
cows. Using ELISA we conﬁrmed in a much larger set of full fat milk
samples that the levels of one of these proteins, LF, were signiﬁ-
cantly increased in low-resistant cows. A positive association was
observed between LF levels in milk and cows that had suffered from
lameness. No signiﬁcant associations were found for LF levels and
metabolic disease, metritis, retained placenta or mastitis. The LF
levels were also associated with culling and had a prognostic value
for culling as low-resistant cows that were culled within one year
had higher LF levels in milk.
The two  potential biomarkers, gGT1 and LF, were selected from
the proteins that were signiﬁcantly different between high- and
low-resistant cows, because these were soluble proteins which
were related to disease in practice and literature. Elevated gGT1
levels in blood is an indicator for cholestasis and liver failure and
is already used in practice. In literature, enhanced gGT1 activity
in serum of Rathi cattle is a marker for stress and metabolic dys-
function (Kataria and Kataria, 2012). Increased gGT1 levels in urine
were related with renal injury (Ferguson et al., 2008). Addition-
ally, gGT1 levels were used as an indicator for colostrum uptake
in young calves and lambs (Maden et al., 2003). Unfortunately, the
gGT1 levels in milk were below the detection limit of the available
capture ELISA, therefore the relevance of gGT1 levels in milk for
bovine health could not be determined in this study. LF levels were
shown to be signiﬁcantly higher in low-resistant cows. Lactofer-
rin has different functions (García-Montoya et al., 2012; Kanwar
et al., 2015; Tothova et al., 2014) and plays e.g. an important role inlimiting the availability of free iron, which is essential for bacterial
growth. Therefore, it might appear counterintuitive that a protec-
tive agent like LF is increased in low-resistant cows, since higher LF
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Fig. 3. LF levels in full fat milk related to mastitis and lameness.
LF  levels were determined in full fat milk samples and related to disease thereby comparing high-resistant cows, low-resistant cows which had suffered from a speciﬁc
disease and low-resistant cows without that particular disease. Individual LF levels were 
data.  (3A) High resistant cows, low-resistant cows which had suffered from mastitis and lo
LF  levels in milk. (3B) Low-resistant cows which had suffered from lameness had signiﬁc
Fig. 4. LF levels in full fat milk and culling.
To determine the prognostic role of LF, LF levels in milk were related to culling. LF
levels in milk were determined in high- and low-resistant cows that were culled or
alive one year after sampling. Individual LF levels were expressed in g/ml. Statistics
were performed on the ln transformed and corrected data. LF levels were lower in
high-resistant cows which were culled compared to high-resistant cows that were
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atill alive (p = 0.041) or low-resistant cows that were still alive (p = 0.017). Low-
esistant cows that were culled had higher LF levels in milk than high-resistant
ows which were still alive (p = 0.035) or culled (p = 0.0017).
evels imply a better protection against disease. However, a similar
ituation is seen for SCC. A higher SCC is usually caused by an inﬂux
f neutrophils in the udder to ﬁght a bacterial infection (Paape et al.,
002). Similar to LF, the higher SCC level helps to control the infec-
ion, which is favourable for the cow. At the same time the higher
CC level is an indication of a recent or ongoing infection, which
ill occur more often in low-resistant cows.
Lactoferrin levels were signiﬁcantly associated with lameness
.e. cows that had suffered from lameness in the past had higher LF
evels in milk. Other studies showed relations between lameness
nd elevated levels of the acute phase proteins serum amyloid A,
aptoglobin and ﬁbrinogen in serum (Kujala et al., 2010; Tóthová
t al., 2011). However, in our milk samples these proteins were
ot signiﬁcantly different in high- and low-resistant cows or were
ot detected at all by NanoLC–MS/MS (Supplementary data 1), sug-
esting that LF was not produced due to an acute phase response.
s we excluded cows with annotations in the months before and
fter sampling, this implies that LF could indicate lameness on aexpressed in g/ml. Statistics were performed on the ln transformed and corrected
w-resistant cows which had suffered from other diseases than mastitis had similar
antly higher LF levels in milk compared to high-resistant cows (p = 0.014).
long term in contrast to e.g. serum amyloid A which indicates an
ongoing infection.
Lactoferrin in milk is released by neutrophils and epithelial cells
and its production is positively related with the inﬂux of neu-
trophils and SCC (Lindmark-Månsson et al., 2006). Since SCC were
on average equal between high- and low-resistant cows (data not
shown), it is less likely that LF levels were increased due to neu-
trophil inﬁltration in the udder. Lactoferrin and haptoglobin levels
in milk were also associated with the energy status of cows (Hiss
et al., 2009). Cows with higher serum NEFAs levels around partu-
rition, an indicator for increased fat mobilisation and a negative
energy balance (NEB), had signiﬁcantly higher LF and haptoglobin
levels in milk for several weeks afterwards. Moreover, cows with
more metabolic stress after calving had more health disorders
(Gross et al., 2011), like lameness (Collard et al., 2000). In line with
this, the low-resistant cows in our study had higher LF levels in
milk, suffered at least two  times from periparturient diseases, and
showed a signiﬁcant association between LF levels and lameness.
Unfortunately, data on the cows‘ energy status was lacking in our
study and a signiﬁcant association between LF levels in milk and
periparturient diseases was  not observed (data not shown).
In contrast to other studies, no association was  observed
between LF levels in milk and SCC (Chaneton et al., 2013; Cheng
et al., 2008; Liu et al., 2010). However, we  selected for cows with
SCC below 250.000 cells/ml and excluded cows with annotations
in the disease registration data in the month before and after sam-
pling, thereby excluding an association with mastitis. In addition,
we found an increase in CD36, BTN1A1, IDH1 and kappa-casein
in milk of low-resistant cows, while others showed these proteins
to be decreased in milk from cows with ongoing mastitis (Huang
et al., 2014; Moyes et al., 2009a). This supports the notion that
the increased LF levels observed in this study were not caused by
mastitis.
Initially, we  found an association between LF levels and disease-
resistance in cows, but a prognostic marker for disease-resistance
would be more valuable. The prognostic value of LF was studied
based on culling rates one year after our analysis. LF levels were sig-
niﬁcantly higher in low-resistant cows that were culled within one
year compared to high-resistant cows. A similar trend was observed
comparing low-resistant cows which were culled or still alive. This
suggest that LF is an indicator for culling risk and might be a result
of repeated health problems. High-resistant cows that were culled
ology 
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ithin one year surprisingly had signiﬁcantly lower LF levels com-
ared to the high-resistant cows that were still alive, suggesting
hat these cows were culled for other reasons than low-resistant
ows. Although, it should be taken into account that the number of
igh-resistant that were culled were low (n = 6). Despite the vari-
bility in basal LF levels between cows (Stelwagen et al., 2009) and
he short half-life of LF in milk (Kutila et al., 2002), we  did show
n association between LF levels in milk and lameness and culling.
ased on our data, a clear cut-off value for LF to indicate “at risk”
ows cannot yet be chosen, but they warrant a more extensive study
o determine the full potential of LF as a biomarker to indicate cows
ith a higher risk to develop health problems.
. Conclusion
In conclusion, using a proteomics approach, we  have established
 potential biomarker for cows with health problems. Low-resistant
ows have higher lactoferrin levels in milk even though these cows
ere clinically healthy at the moment of sampling. The LF levels
ere positively associated with lameness and may  be a long term
ndicator for this disease. Moreover, cows with high LF levels were
ore likely to have been culled one year after sampling, indicat-
ng that LF has potential as a prognostic biomarker for premature
ulling.
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